drug development

Amgen And Avalere Reports Reveal "Upside Down" Payer Biosimilar Realities
Amgen And Avalere Reports Reveal "Upside Down" Payer Biosimilar Realities
Biosimilar Development
Amgen
Avalere
biosimilars
drug development
payers
Flag link:
Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk
Former FDA commissioner Califf to pharma: opening up on health data requires overcoming risk
Medical Marketing and Media
Robert Califf
drug development
Flag link:
Roche pens death notice for NewLink IDO/TDO cancer collaboration
Roche pens death notice for NewLink IDO/TDO cancer collaboration
Fierce Biotech
Roche
NewLink Genetics
IDO/TDO inhibitors
drug development
Flag link:
Australian and US Scientists Discover New Insights into Dementia and Alzheimer’s
Australian and US Scientists Discover New Insights into Dementia and Alzheimer’s
CP Wire
Alzheimer's disease
dementia
drug development
Australia
Flag link:
Exelixis and Invenra Partner to Develop Novel Biologics for Cancer Treatment
Exelixis and Invenra Partner to Develop Novel Biologics for Cancer Treatment
CP Wire
Exelixis
Invenra
cancer
Merck
drug development
Flag link:
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge
FluGen May Seek Funding from $12M Gates-Backed Flu Vaccine Challenge
Xconomy
FluGen
drug development
universal flu vaccine
Bill Gates
Flag link:
La Jolla's Synthorx raises $63 million to make cancer drugs from bacterium with artificial DNA
La Jolla's Synthorx raises $63 million to make cancer drugs from bacterium with artificial DNA
San Diego Union Tribune, CA
Synthorx
drug development
Flag link:
Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Biogen To Pay Ionis $1 Billion To Develop Brain Drugs
Forbes
Biogen
Ionis Pharmaceuticals
drug development
R&D
Flag link:
FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma
FDA chief Scott Gottlieb promises to streamline drug development pathway for biopharma
Endpoints
FDA
Scott Gottlieb
drug development
Flag link:
Nosopharm and University of Chicago Researchers Report on New Class of Antibiotics
Nosopharm and University of Chicago Researchers Report on New Class of Antibiotics
CP Wire
Nosopharm
antibiotics
drug development
Flag link:
FDA Wants to Know What Prevents Exposure-Response Analyses in Drug Development
FDA Wants to Know What Prevents Exposure-Response Analyses in Drug Development
RAPS.org
FDA
exposure-response analyses
drug development
Flag link:
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Eli Lilly inks $63m deal with Sigilon to develop encapsulated cell therapies for diabetes
Drug Delivery Business News
Eli Lilly
Sigilon
cell therapies
drug development
type 1 diabetes
Flag link:
Pfizer signs deal with Allogene to develop cancer cell therapy
Pfizer signs deal with Allogene to develop cancer cell therapy
Yahoo/Reuters
Pfizer
Allogene
CAR-T
drug development
Flag link:
Compugen, AstraZeneca unit in cancer drug development deal
Compugen, AstraZeneca unit in cancer drug development deal
Yahoo/Reuters
AstraZeneca
CompuGen
drug development
MedImmune
cancer
Flag link:
Celgene, bluebird revise deal to co-develop CAR-T therapy
Celgene, bluebird revise deal to co-develop CAR-T therapy
Biopharma Dive
Celgene
Bluebird Bio
drug development
CAR-T
bb2121
Multiple Myeloma
Flag link:
CDI Labs' Monoclonal Antibody Development Pipeline Featured in Nature Methods
CDI Labs' Monoclonal Antibody Development Pipeline Featured in Nature Methods
CP Wire
CDI Labs
monoclonal antibodies
drug development
Flag link:
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Teva calls off CGRP drug discovery and development pact, returns preclinical asset to Sosei
Endpoints
Teva Pharmaceutical
CGRP blockers
R&D
drug development
Heptares Therapeutics
Flag link:
Vividion Lands $101M from Celgene to Develop Protein-Targeting Drugs
Vividion Lands $101M from Celgene to Develop Protein-Targeting Drugs
Xconomy
Vividion
Celgene
drug development
protein-targeted drugs
Flag link:
Despite push for a universal flu vaccine, the ‘holy grail’ stays out of reach
Despite push for a universal flu vaccine, the ‘holy grail’ stays out of reach
Stat
drug development
Flu
flu vaccines
universal flu vaccine
Flag link:
Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance
Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance
RAPS.org
Pfizer
Roche
Allergan
FDA
patients
drug development
Flag link:

Pages